Sands China Recognised by S&P Global's Sustainability Yearbook for Fourth Consecutive Year
Sands China Ltd. has been recognized by the S&P Global Sustainability Yearbook for the fourth consecutive year, achieving Top 1% rankings in both the Global and China editions for its Corporate Sustainability Assessment (CSA) scores. The company also received the 'Industry Mover' distinction in the China edition for the second consecutive year, highlighting its exceptional performance in environmental, social, and governance (ESG). Grant Chum, CEO, emphasized that these achievements affirm Sands China's continued investment in sustainable operating strategies and positive long-term social impact.
Trump lauds Citi as No. 1 in M&A advisor by deal value, but is it? (C:NYSE)
Former President Donald Trump congratulated Citi for ranking Number 1 in the M&A advisory market by deal value in Q1, according to a social media post on Wednesday. The article questions the accuracy of this claim while highlighting Trump's specific praise for "Jane F and ALL of her great people."
J&J faces $32M jury award over talc-related cancer case (JNJ)
Johnson & Johnson (JNJ) has been ordered to pay $32 million by a Los Angeles jury in a talc-related cancer case. The award was granted to the family of a California woman who died from pleural mesothelioma, allegedly linked to her use of the company's talc products. This verdict adds to the ongoing legal challenges J&J faces regarding its talc-based products.
SLB's Role in the Expansion of bp's Thunder Horse Oil Field
SLB OneSubsea has secured a contract from bp to provide a subsea boosting system for the Thunder Horse oil field in the Gulf of Mexico. This is the third deepwater oil project for which bp has engaged SLB OneSubsea, indicating a standardized approach across its Kaskida and Tiber developments as well. The subsea boosting technology is crucial for maintaining hydrocarbon flow in mature fields like Thunder Horse, which began production in 2008 and holds over a billion barrels of oil.
Truist expands commercial mortgage servicing business
Truist Financial Corporation, through its subsidiary Grandbridge Real Estate Capital, has expanded its commercial mortgage servicing business by launching a Master Servicing platform. This move strengthens Truist's position as a leader in commercial real estate and allows Grandbridge to manage complex commercial mortgage-backed securities (CMBS) transactions from origination to long-term administration. The platform aims to provide comprehensive support to real estate owners and underscores Truist's commitment to its Wholesale Banking platform.
IDEXX Laboratories Stock’s 63% Gross Margin Story: Here’s What the Numbers Say About a $909 Target
IDEXX Laboratories reported strong Q1 2026 results with 14% revenue growth and gross margins reaching 63%, driven by increased diagnostic utilization despite declining clinical visits. The company raised its full-year 2026 guidance, and TIKR's analysis suggests IDEXX stock could reach approximately $909 by December 2030, representing a significant total return. The investment thesis hinges on the continued expansion of recurring revenue and operating leverage.
Bernstein SocGen reiterates Rockwell Automation stock rating By Investing.com
Bernstein SocGen maintained a Market Perform rating and a $501.00 price target for Rockwell Automation (NYSE: ROK), noting that while the company has an ambitious growth algorithm, much of these expectations are already priced into the stock. Rockwell Automation is trading near its 52-week high with a P/E ratio of 47.38 and is considered overvalued. The firm will monitor CapEx cycles, reshoring benefits, and vertical growth as key performance drivers, highlighting recent initiatives like a $1 billion share buyback, enhanced cybersecurity, and AI-powered energy efficiency solutions.
Pfizer Stock 2026: CEO Lays Out the Case for a Growth Surge
Pfizer CEO Albert Bourla presented at the Goldman Sachs 47th Annual Global Healthcare Conference, addressing concerns about revenue loss post-COVID demand decline and outlining a strategy for growth by 2029. He highlighted the fixes made to commercial and manufacturing models, and a refocused R&D pipeline that is starting to show results with strong Q1 2026 growth in new launches and the Seagen portfolio. The article emphasizes upcoming clinical data, particularly the Phase 3 results for sigvotatug vedotin and the long-term potential of the obesity program, as critical catalysts for Pfizer's stock performance.
Dividend Safety Check: EWO and Austrian Equity Income
The iShares MSCI Austria ETF (EWO) offers concentrated exposure to Austrian equities, with its semi-annual dividend heavily reliant on the banking and insurance sectors. While EWO has seen significant capital appreciation, its dividend is lumpy and susceptible to regulatory changes, as evidenced by a 2020 payout cut. For new buyers, the forward yield may not clear risk-free rates, making it more suited as a total-return vehicle than a reliable income source.
Why Marathon Petroleum Stock Looks Interesting After Its Q1 2026 Operating Leverage Inflection
Marathon Petroleum (MPC) saw a strong Q1 2026, with total revenues up 9% year-over-year and operating income surging 172%, ending five quarters of decline. The company benefited from geopolitical shifts affecting global refined products capacity and strategic crude sourcing. TIKR's mid-case model projects a value of approximately $319 by December 2034, suggesting a 24% total return from its current price, contingent on net income margins recovering to 4% and EPS growing at roughly 12% annually.










